Posted on 14/12/07
MDS unfazed by isotope problem
MDS Inc., the Canadian life sciences company caught in the crossfire of Ottawa's medical isotope controversy, says it won't take as big a financial hit from the Chalk River reactor shutdown as it originally expected.
The full text of this article has 632 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
